Pacific Biosciences of California, Inc.
PACB
$1.32
$0.043.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 75.04% | 80.45% | -76.34% | -27.75% | -31.46% |
| Total Depreciation and Amortization | -58.01% | -183.24% | -54.99% | -43.97% | -3.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -103.48% | 304.79% | 346.84% | 110.68% | 123.97% |
| Change in Net Operating Assets | 151.97% | 156.77% | 110.95% | 109.38% | 70.85% |
| Cash from Operations | 21.06% | 35.88% | 46.03% | 47.29% | 40.82% |
| Capital Expenditure | -94.04% | -18.12% | 56.14% | 47.38% | 66.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.69% | -70.81% | -9.24% | 2,511.94% | -31.83% |
| Cash from Investing | -20.39% | -47.84% | -6.90% | 18,351.79% | -30.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -5,268.98% | -3,432.72% |
| Issuance of Common Stock | 14.07% | 4.87% | -55.50% | -60.32% | -77.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 106.66% | 106.11% | 107.97% | 37.13% | 37.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.23% | 84.63% | 106.13% | 92.89% | 59.03% |